Renal failure in cirrhosis.

By P. Ginés, R. Schrier. New England Journal of Medicine, 2009

791 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/3edcfc4d61415b483e59c250623c430faf8b8d46

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Citations in the corpus

Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases (2021, background): “Differentiating ATN from the severe form of HRS-AKI is particularly challenging because of the lack of clear diagnostic indicators (15, 215, 218-220, 223, 224).”
Hepatorenal syndrome: the 8th international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group (2012, background): “5 mg/dl) or a deterioration in kidney function that does not fulfill the criteria for HRS type-1 [1].”
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. (2018, background): “Current strategies for prophylaxis and treatment of decompensation and organ failure in cirrhosis rely on measures aimed to prevent or improve the outcome of each complication, that is renal sodium retention leading to ascites formation, ammonia production in hepatic encephalopathy, effective hypovo”
Acute-on chronic liver failure. (2012, background): “HRS is thought to be a functional disorder secondary to circulatory dysfunction in which there is splanchnic vasodilatation, a lowering of arterial blood pressure, intense renal vasoconstriction, impaired cardiac function and marked activation of the sympathetic and neurohormonal systems [93–95].”
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014 (2009, unknown): “In patients with decompensated cirrhosis, the main abnormality causing renal dysfunction is systemic and splanchnic vasodilatation secondary to portal (or sinusoidal) hypertension that leads to decreased effective arterial blood volume and activation of neurohormonal systems, the rennin–angiotensin ”
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update (2019, background): “Decreased frequency of DCs and high IFN-γ levels correlate with poor patient survival [104].”